Switch theme
Sign up to access all valuation multiples
Krakchemia SA is Poland-based firm. The company is engaged in manufacturing and trading of chemical products. The company product portfolio includes products like packaging film, laboratory chemicals, chemicals materials, and trading of plastic raw materials. In addition, the company is also in the possession of a modern fleet of longitudinal film cutting and rolling machines. Majority of its revenue comes from the Poland market, while it also has a presence in Slovakia, Czech Republic, Germany and other foreign markets.
1945
n/a
Last FY Revenue $12.4M
Last FY EBITDA -$1.6M
$2.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Krakchemia achieved revenue of $12.4M and an EBITDA of -$1.6M.
Krakchemia expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Krakchemia valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $12.4M | XXX | XXX | XXX |
| Gross Profit | XXX | $1.6M | XXX | XXX | XXX |
| Gross Margin | XXX | 13% | XXX | XXX | XXX |
| EBITDA | XXX | -$1.6M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -13% | XXX | XXX | XXX |
| EBIT | XXX | -$1.7M | XXX | XXX | XXX |
| EBIT Margin | XXX | -13% | XXX | XXX | XXX |
| Net Profit | XXX | -$3.7M | XXX | XXX | XXX |
| Net Margin | XXX | -30% | XXX | XXX | XXX |
| Net Debt | XXX | $0.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 18, 2025, Krakchemia's stock price is PLN 1 (or $0).
Krakchemia has current market cap of PLN 8.4M (or $2.3M), and EV of PLN 9.2M (or $2.6M).
See Krakchemia trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.6M | $2.3M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 18, 2025, Krakchemia has market cap of $2.3M and EV of $2.6M.
Krakchemia's trades at 0.2x EV/Revenue multiple, and -1.6x EV/EBITDA.
Equity research analysts estimate Krakchemia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Krakchemia's P/E ratio is not available.
See valuation multiples for Krakchemia and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.3M | XXX | $2.3M | XXX | XXX | XXX |
| EV (current) | $2.6M | XXX | $2.6M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -1.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -1.5x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -0.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -34.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialKrakchemia's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Krakchemia's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Krakchemia's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Krakchemia and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -13% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Krakchemia acquired XXX companies to date.
Last acquisition by Krakchemia was XXXXXXXX, XXXXX XXXXX XXXXXX . Krakchemia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Krakchemia founded? | Krakchemia was founded in 1945. |
| Where is Krakchemia headquartered? | Krakchemia is headquartered in Poland. |
| Is Krakchemia publicy listed? | Yes, Krakchemia is a public company listed on WAR. |
| What is the stock symbol of Krakchemia? | Krakchemia trades under KCH ticker. |
| When did Krakchemia go public? | Krakchemia went public in 2007. |
| Who are competitors of Krakchemia? | Similar companies to Krakchemia include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of Krakchemia? | Krakchemia's current market cap is $2.3M |
| Is Krakchemia profitable? | Yes, Krakchemia is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
